1. 074 Long-term effect of idebenone in reducing respiratory function decline in patients with Duchenne muscular dystrophy. Issue 6 (27th May 2022) Authors: Servais, L; Mayer, OH; McDonald, CM; Voit, T; Mercuri, E; Buyse, GM Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93:Issue 6(2022) Page Start: A35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. D.08 ACT DMD (Ataluren Confirmatory Trial in Duchenne Muscular Dystrophy): effect of Ataluren on timed function tests (TFT) in nonsense mutation (nm) DMD. (17th June 2016) Authors: Goemans, N; Campbell, C; McDonald, CM; Voit, T; Luo, X; Elfring, G; Kroger, H; Riebling, P; Ong, T; Spiegel, R; Peltz, SW; Bushby, K Journal: Canadian journal of neurological sciences Issue: Volume 43(2016)Supplement 2 Page Start: S15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Laing early onset distal myopathy: slow myosin defect with variable abnormalities on muscle biopsy. Issue 2 (15th August 2005) Authors: Lamont, P J; Udd, B; Mastaglia, F L; de Visser, M; Hedera, P; Voit, T; Bridges, L R; Fabian, V; Rozemuller, A; Laing, N G Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 77:Issue 2(2006) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Mutational diversity and hot spots in the alpha-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D). Issue 6 (June 1997) Authors: Carrié, A; Piccolo, F; Leturcq, F; de Toma, C; Azibi, K; Beldjord, C; Vallat, J M; Merlini, L; Voit, T; Sewry, C; Urtizberea, J A; Romero, N; Tomé, F M; Fardeau, M; Sunada, Y; Campbell, K P; Kaplan, J C; Jeanpierre, M Journal: Journal of medical genetics Issue: Volume 34:Issue 6(1997) Page Start: 470 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker–Warburg syndrome. Issue 5 (30th April 2004) Authors: Beltran-Valero de Bernabé, D; Voit, T; Longman, C; Steinbrecher, A; Straub, V; Yuva, Y; Herrmann, R; Sperner, J; Korenke, C; Diesen, C; Dobyns, W B; Brunner, H G; van Bokhoven, H; Brockington, M; Muntoni, F Journal: Journal of medical genetics Issue: Volume 41:Issue 5(2004) Page Start: e61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P236Evaluation of safety and feasibility of Mybpc3 gene therapy in a mouse model of hypertrophic cardiomyopathy. (15th July 2014) Authors: Mearini, G; Simpel, D; Geertz, B; Kraemer, L; Schlossarek, S; Weinberger, F; Mueller, O; Voit, T; Eschenhagen, T; Carrier, L Journal: Cardiovascular research Issue: Volume 103(2014)Supplement 1 Page Start: S42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Patterns and predictors of sleep disordered breathing in primary myopathies. Issue 8 (1st August 2002) Authors: Ragette, R; Mellies, U; Schwake, C; Voit, T; Teschler, H Journal: Thorax Issue: Volume 57:Issue 8(2002) Page Start: 724 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗